Moreover, the MIC of 2.78 μM for Ll-LEAP2 against S. enterica and E. coli was considered to be relatively low, suggesting that this peptide can potentially inhibit S. enterica and E. coli infections. Here, LEAP2 is linked to escherichia coli infection.